Iosifina Karmaniolou, MD Georgios Petropoulos, MD, PhD Kassiani Theodoraki, MD, PhD

Can J Anesth/J Can Anesth (2011) 58:650–657 DOI 10.1007/s12630-011-9508-4 REVIEW ARTICLE/BRIEF REVIEW Management of idiopathic intracranial hyperten...
Author: Julianna Hunt
0 downloads 0 Views 220KB Size
Can J Anesth/J Can Anesth (2011) 58:650–657 DOI 10.1007/s12630-011-9508-4

REVIEW ARTICLE/BRIEF REVIEW

Management of idiopathic intracranial hypertension in parturients: anesthetic considerations Prise en charge de l’hypertension intracraˆnienne idiopathique chez la parturiente: conside´rations anesthe´siques Iosifina Karmaniolou, MD • Georgios Petropoulos, MD, PhD Kassiani Theodoraki, MD, PhD



Received: 13 December 2010 / Accepted: 8 April 2011 / Published online: 26 April 2011 Ó Canadian Anesthesiologists’ Society 2011

Abstract Purpose Idiopathic intracranial hypertension (IIH) is a rare condition characterized by raised intracranial pressure (ICP) without related pathology in either the brain or the composition of cerebrospinal fluid (CSF). Herein, we provide a brief review of the clinical presentation of IIH and the anesthetic considerations in parturients diagnosed with the disorder. Source We conducted a MEDLINEÒ literature search for all types of articles published in English with restriction for year of publication, and we used the search terms ‘‘idiopathic intracranial hypertension’’, ‘‘pseudotumor cerebri’’, ‘‘benign intracranial hypertension’’, ‘‘pregnancy’’, ‘‘cesarean section’’, ‘‘labour analgesia’’, ‘‘epidural’’, and ‘‘anesthesia’’. Principal findings Idiopathic intracranial hypertension affects primarily obese women of childbearing age. The main symptom is headache, and the cardinal sign is papilledema. The main goal of management is to preserve visual function. Treatment lies in the administration of diuretics and corticosteroids, control of excessive weight gain, and surgical management, such as cerebrospinal fluid diversion or optic nerve sheath fenestration for refractory cases. For the parturient with IIH, Cesarean delivery is not necessarily indicated. Neuraxial anesthesia has been used uneventfully for both labour analgesia and for Cesarean delivery. There are reports describing I. Karmaniolou, MD  G. Petropoulos, MD, PhD  K. Theodoraki, MD, PhD Department of Anesthesia, Aretaieio Hospital, Medical School, University of Athens, Athens, Greece I. Karmaniolou, MD (&) Halkomatadon 35, Perissos, 14232 Athens, Greece e-mail: [email protected]

123

successful use of both spinal and epidural anesthesia, even in IIH patients with CSF diversion devices in situ. Conclusion Although IIH is rare, there are special considerations for anesthetic management in the parturient. Despite the presence of raised ICP in these patients, there are no specific contraindications to neuraxial techniques, and uncal herniation has not been reported to occur in patients with IIH. Re´sume´ Objectif L’hypertension intracraˆnienne idiopathique (HII) est une condition rare qui se caracte´rise par une pression intracraˆnienne (PIC) e´leve´e sans pathologie connexe au niveau du cerveau ou de la composition du liquide ce´phalorachidien (LCR). Nous proposons ici une bre`ve synthe`se de la pre´sentation clinique de l’HII et quelques conside´rations anesthe´siques chez les parturientes avec un diagnostic de ce trouble. Source Nous avons re´alise´ une recherche de la litte´rature sur MEDLINEÒ pour extraire tous les articles publie´s en anglais en posant comme contrainte l’anne´e de publication, et avons utilise´ les termes de recherche « idiopathic intracranial hypertension » (hypertension intracraˆnienne idiopathique), « pseudotumor cerebri » (me´ningite se´reuse), « benign intracranial hypertension » (hypertension intracraˆnienne be´nigne), « pregnancy » (grossesse), « cesarean section » (ce´sarienne), « labour analgesia » (analge´sie pour le travail obste´trical), « epidural » (pe´ridurale), et « anesthesia » (anesthe´sie). Constatations principales L’hypertension intracraˆnienne idiopathique affecte principalement les femmes obe`ses en aˆge de procre´er. Les ce´phale´es sont le symptoˆme principal, et le symptoˆme cardinal est l’œde`me papillaire. L’objectif principal de la prise en charge est de conserver la fonction visuelle. Le traitement consiste a` administrer des diure´tiques

Idiopathic intracranial hypertension and pregnancy

et des corticoste´roı¨des, a` controˆler une prise de poids excessive, et a` effectuer une prise en charge chirurgicale, telle que le de´tournement du liquide ce´phalorachidien ou la fenestration de la gaine du nerf optique dans les cas re´fractaires. L’accouchement par ce´sarienne n’est pas force´ment indique´ chez la parturiente atteinte d’HII. L’anesthe´sie neuraxiale a e´te´ utilise´e sans complication pour l’analge´sie du travail obste´trical et pour les accouchements par ce´sarienne. Certains cas rapporte´s de´crivent l’utilisation re´ussie d’anesthe´sie rachidienne et de pe´ridurale, meˆme chez les patientes atteintes d’HII et chez lesquelles e´taient positionne´s des appareils de de´rivation du LCR. Conclusion Bien que l’HII soit rare, certaines conside´rations particulie`res s’appliquent a` la prise en charge anesthe´sique de la parturiente atteinte de ce trouble. Malgre´ la pre´sence d’une PIC e´leve´e chez ces patientes, il n’existe pas de contre-indication spe´cifique aux techniques neuraxiales, et on n’a pas rapporte´ d’hernie uncine´e chez les patientes atteintes d’HII.

Idiopathic intracranial hypertension (IIH) is defined as a neurological disorder characterized by raised cerebrospinal fluid pressure (CSF) in the absence of any intracranial pathology or secondary cause of intracranial hypertension.1 It was first described by Quinke in 1893 under the name of ‘‘meningitis serosa’’.2 This condition was known as pseudotumor cerebri and benign intracranial hypertension until 1989 when Corbett and Thomson suggested its current term.3 In the general population, IIH occurs at a rate of 0.9/100,000 per year.4 It is more prevalent in women of childbearing age,5 especially obese persons.6-8 In a cohort study in Iowa and Louisiana, the female-to-male ratio was estimated to be 8:1.4 In the same study, the incidence increased to 19.3/100,000 for obese women ages 20 to 44.4 Pregnancy occurs in IIH patients at the same rate as for the general population, and subsequent pregnancies do not seem to increase the risk of recurrence.9,10 Rare cases of familial IIH have been described.11,12 In pregnant women with IIH, normal deliveries are usually expected. Some authors suggest that the second stage of labour can be shortened by instrumental delivery if deemed necessary to avoid a further increase in ICP.13,14 In our view a prolonged second stage labour in these patients is no specific cause for concern; furthermore, IIH is not in itself a specific indication for Cesarean delivery.15 We undertook to review the symptoms, pathogenesis, management, and anesthetic considerations in parturients with IIH. We conducted a MEDLINEÒ literature search for all types of articles published in English with restriction for

651

year of publication, and we used the search terms ‘‘idiopathic intracranial hypertension’’, ‘‘pseudotumor cerebri’’, ‘‘benign intracranial hypertension’’, ‘‘pregnancy’’, ‘‘cesarean section’’, ‘‘labour analgesia’’, ‘‘epidural’’, and ‘‘anesthesia’’. The search identified only 14 articles that specifically addressed the anesthetic management of parturients with IIH. We considered all articles that helped to characterize the nature of IIH and the clinical presentation and management of the disorder. Since randomized prospective data were lacking, we considered case reports, case series, and retrospective studies. Presentation and pathogenesis of IIH The most frequent symptom of IIH is headache, occurring in more than 90% of cases.16,17 The headache is usually generalized, worse in the morning, and may be associated with photophobia.18 Also, patients may report neck, back, and shoulder pain, although less frequently.4,13 Other symptoms include nausea, vomiting, and pulsatile tinnitus (in up to 60% of cases).19 Visual disturbances are a common manifestation and include visual field loss, transient visual obscurations, loss of visual acuity, as well as diplopia resulting from sixth nerve palsy.20,21 The cardinal sign is papilledema, although, albeit rarely, it might be absent22,23 or unilateral.24,25 The major risk of IIH is visual loss, which can be permanent despite therapy.26 Untreated papilledema can lead to permanent blindness in up to 10% of patients.27,28 On rare occasions, seventh29 and fourth30 nerve palsies have been reported, the latter in pediatric patients. It seems that symptoms worsen during pregnancy in 50% of patients and usually resolve postpartum.31,32 Although the pathogenesis of raised intracranial pressure in IIH remains unclear, the most widely accepted theory is impaired absorption of CSF in the arachnoid villi. It has been suggested that this might be due to raised venous pressure from venous outflow obstruction.33-35 Sugerman et al. suggested that the raised ICP in obese IIH subjects is secondary to the increased cardiac filling pressures caused by increased abdominal pressure.36 It has recently been suggested that jugular venous insufficiency plays a causal role.37

Diagnosis and treatment of IIH Diagnosis is based mostly on the ‘‘modified Dandy criteria’’ updated by Friedman and Jacobson in 200238 (Table 1). Imaging of the brain should be carried out before a lumbar puncture, and magnetic resonance imaging (MRI) is the current diagnostic testing of choice.39 Neuroimaging studies are usually normal, although, in some cases, they

123

652 Table 1 The Modified Dandy Criteria for diagnosis of IIH38 Symptoms of raised intracranial pressure No localizing signs with the exception of sixth nerve palsy CSF pressure of 25 mmHg or greater measured in the lateral decubitus position Normal CSF composition Patient awake and alert Normal neuroimaging studies without evidence of thrombosis, except for an empty sella No other explanation for the raised intracranial pressure IIH = idiopathic intracranial hypertension; CSF = cerebrospinal fluid

may demonstrate partially empty sella and perioptic CSF distension or small ventricles.40 Therapeutic measures should be focused towards preserving visual function. Medical treatment includes diuretics (mainly acetazolamide), steroids, and serial lumbar punctures. De Simone et al. suggest CSF drainage in increments of 20 mL.41 Cerebrospinal fluid drainage volumes as high as 45 mL have been reported.42 Symptoms may resolve even after a single lumbar puncture, but, if needed, the puncture can be repeated at intervals spaced over several weeks. Generally, the CSF is drained until the pressure falls to normal levels or below 20 mmHg.43,44 Prednisone has been reported to achieve resolution of symptoms in a parturient within three days.45 Parturients should be advised to avoid excessive weight gain.28 A lowcalorie diet or weight loss program, generally indicated in non-pregnant patients with IIH, may not be the recommendation of choice in the parturient because of the high nutritional requirements of the parturient and the developing fetus. If these measures fail to improve visual function, then surgical management becomes necessary, including lumboperitoneal shunting46,47 or ventriculoperitoneal shunting procedures48,49 or optic nerve sheath fenestration.50,51 Optic nerve sheath fenestration is usually undertaken when visual loss is prominent.52 An incision is made in the retrobulbar optic nerve dural sheath, thus allowing a reduction in the pressure exerted on the optic nerve.53 Optic nerve sheath fenestration has the advantage of requiring less anesthesia time, which is always an important consideration during pregnancy. All methods of management have a recognized failure rate with frequent need for revisions in some patients.52 Such procedures have been carried out in parturients with IIH without adverse outcome on the pregnancy.54,55 Acetazolamide, a carbonic anhydrase inhibitor, lowers intracranial pressure by reducing the production of CSF. However, carbonic anhydrase inhibitors may be teratogenic and have been associated with forelimb abnormalities in rats and mice.56-58 Within the United States Food and Drug Administration classification of pregnancy risk, the risk is

123

I. Karmaniolou et al.

considered category C (meaning that animal studies have shown an adverse effect, but there no adequate and wellcontrolled studies in pregnant women). Nevertheless, in their review, Lee et al. concluded that there are no welldocumented reports of adverse effects of acetazolimade on pregnancy.59 They recommend to consider acetazolamide if there is a high risk of visual loss. Overall, since safety in pregnancy cannot be established, we suggest that carbonic anhydrase inhibitors should be administered with caution, at least during the first trimester or until the 20th week of pregnancy.21

Anesthetic considerations for the parturient with IIH As mentioned previously, IIH is not in itself an indication for Cesarean delivery; patients diagnosed with IIH might require labour analgesia or anesthesia for Cesarean delivery for indications unrelated to IIH. Although dural puncture is contraindicated in patients with increased ICP resulting from space occupying lesions, a risk of uncal herniation does appear to exist in patients with IIH.60 As described previously, lumbar puncture may be therapeutic in IIH patients as it decreases CSF pressure and consequently improves symptoms. It has been postulated that the uniform swelling and stiffness of the brain in IIH prevents herniation.60 On rare occasions, it has been reported that herniation was associated with an anatomic variation, i.e., low-lying cerebellar tonsils.61 Herniation, on the other hand, is an identified late complication of lumboperitoneal shunts.62,63 In this case, it seems that the lumboperitoneal shunt creates a craniospinal pressure gradient due to the continuous CSF drainage, which acts as a driving force for tonsillar descent and subsequent herniation.64 Moreover, months after placement of the shunt, the brain eventually loses its stiffness to a point that it is compliant enough to herniate. Vaginal delivery and anesthesia During routine vaginal delivery, the uterus empties approximately 300 mL of blood into the circulation with each myometrial contraction. Cerebrospinal fluid pressure increases in response to myometrial contractions and is associated with increases in central venous pressure, stroke volume, cardiac output, and arterial blood pressure.32 Although such increases in CSF pressure are independent of pain, pain may exaggerate the response. Specifically, elevations in ICP are related to skeletal muscle contractions in response to pain, so that epidural analgesia might in fact attenuate rises in ICP.65 Neuraxial analgesia for labour has been carried out without complications in parturients with IIH66,67 (Table 2). However, there have been concerns that

653

IIH = idiopathic intracranial hypertension; LP = lumboperitoneal; t.d. = test dose; PDPH = postdural puncture headache; CSF = cerebrospinal fluid

Douglas

? fentanyl 2 lgmL-1 for 9 hr

No No N/A Bolus: 0.25% bupivacaine 8 mL Epidural / NA No

After 70 min: 0.5% bupivacaine 8 mL

80

No Palop66

Infusion: 0.125% bupivacaine 8 mLhr-1

No No 0.5% bupivacaine 6 mL

N/A

No Aly27

Epidural L3-4 / 17 G Tuohy

t.d. 0.5% bupivacaine 2 mL

Postpartum headache for two days (not PDPH)

Yes / L2-3 Kaul14

Infusion: 1 mL /3 hr for 13 hr

0.5% hyperbaric bupivacaine 1 mL

Epidural catheter intrathecally L3-4 / 18G Tuohy

Motor block T7 sensory

Prior radiograph to locate the shunt Drainage of 25 mL of CSF before anesthesia

Forceps used;

Hypotension/Accidental spinal catheter (left in place and used) T5 motor t.d. 1.5% lidocaine 3 mL (20 min) lidocaine 10 mg (15 min) Epidural L1-2 / 17G Hustead

Complications Level Volumes of local anesthetic (duration) Anesthetic technique Interspace / Needle Presence of LP shunt / Interspace First AuthorRef

Table 2 Anesthetic techniques for vaginal delivery in patients with IIH

Other comments

Idiopathic intracranial hypertension and pregnancy

large volumes of local anesthetic administered epidurally might elevate intracranial pressure even more in patients with intracranial hypertension.68 Using a porcine model, Grocott et al. demonstrated that the elevation in ICP is significantly greater in the presence of intracranial hypertension.68 Similarly, Hilt et al. have recorded a great increase in ICP in a patient with intracranial hypertension following lumbar extradural injection of bupivacaine 10 mL, even though the study was not specific for IIH.69 Accordingly, cerebral blood flow is reduced markedly for a short time after injection. For this reason, vaginal delivery using an intrathecal catheter has also been suggested.27 In fact, Aly et al. claim that an intrathecal catheter creates the possibility of therapeutic CSF drainage if symptoms deteriorate during labour.27 Similarly, in an effort to minimize abrupt increases in ICP, epidural infusion has been suggested instead of intermittent bolus dosing.70 Analgesic drugs that might cause respiratory depression and a consequent rise in ICP, mainly opioids, are best avoided. Anesthesia for Cesarean delivery Neuraxial anesthesia, epidural or spinal, has been used successfully for Cesarean delivery in patients with IIH70-72 (Table 3). Since lumbar puncture for CSF drainage is a therapeutic modality for IIH, there is no indication to withhold spinal anesthesia in these patients.71 However, when using epidural techniques for Cesarean delivery, one should consider that the large volumes of drugs administered into the epidural space for surgical anesthesia possibly may carry a risk of raising intracranial pressure in these patients.27 On the other hand, special consideration should be given for parturients who have been subjected to recent CSF removal, as the risk of a higher than anticipated block or even a total spinal may be present.27 Anesthesia for IIH patients with shunts There are special considerations for IIH patients with a lumboperitoneal shunt where there are conflicting recommendations to use either general or neuraxial anesthesia. Some authors advocate the use of general anesthesia without evidence of adverse effects with neuraxial techniques,31,71 while others report use of epidural or spinal anesthesia without complications.14,72,73 A primary issue of concern is potential damage to the shunt catheter by the epidural or spinal needle.10,71 Heckathorn et al. used a spinal catheter that had been inserted ten days prior for CSF drainage, withdrawing the catheter from 20 to 15 cm. The patient received hyperbaric bupivacaine 11.25 mg, fentanyl 10 lg, and morphine 300 lg with the catheter clamped throughout the procedure.74 The location of the catheter tip is important

123

123

No

No

No

Yes / NA

No

Bagga31

Palop66

Bedson70

Abuleish71

Case 1

Yes L3-4

No

Be´dard73

Heckathorn74 Spinal catheter in place used for drainage L4-5

Epidural T12-L1 (replacement)

Epidural L4-5 /NA

Epidural L1-2 / NA

Spinal L3-4 /22G

CSE L2-3 / 16G Tuohy 27G Whitacre

Epidural L3-4 / NA

GA

Anesthetic technique Interspace / Needle

bupivacaine 11.25 mg ? fentanyl 10 lg ? morphine 0.3 mg (90 min)

For CS: t.d. 1.5% lidocaine 3 mL ? epinephrine 5 lgmL-1, 2% lidocaine 15 mL ? fentanyl 100 lg (90 min)

Infusion: 0.125% bupivacaine 10 mLhr-1 ? fentanyl 2 lgmL-1 for 7 hr

Initially for labour: t.d lidocaine 3 mL ? epinephrine 5 lgmL-1 ? 3 bolus doses

For CD: 2% lidocaine ? 1:200,000 epinephrine ? HCO3-, volume: 15 mL (1 ‘ hr)

For vaginal: 0.2% ropivacaine 5-7 mLhr-1 (for 19 hr)

5% lidocaine 60 mg in 7.5% D/W ? epinephrine 0.2 mg (4 segment regression in 120 min)

GA - RSI

Spinal: bupivacaine 11 mg ? fentanyl 25 lg volume: 2.7 mL

For CD: 0.5% bupivacaine 10 mL

Initially for labour: t.d. 0.5% bupivacaine 2 mL ? 4 doses of 6 mL in 5 hr

Volumes of local anesthetic (duration)

T5 sensory

T8 sensory before drapes were placed

T8 sensory left

T10 sensory right

Motor weakness

T4 sensory

T4 sensory

T3 sensory

T10 sensory T6 sensory

Level

Catheter clamped throughout the procedure

CD due to non progression of vaginal delivery

Failure after 7 hr of infusion replacement

Epidurogram before removal of the catheter

CD due to non progression of vaginal delivery

Hypotension

No

No

CD due to non progression of vaginal delivery

No

ComplicationsComments

IIH = idiopathic intracranial hypertension; LP = lumboperitoneal; YES CSE = combined spinal-epidural; GA = general anesthesia; RSI = rapid sequence induction; t.d. = test dose; CD = Cesarean delivery; D/W = Dextrose in Water

Yes / L4-5

Kim72

Case 2

Presence of LP shunt / Interspace

First AuthorRef

Table 3 Anesthesia for Cesarean delivery in patients with IIH

654 I. Karmaniolou et al.

Idiopathic intracranial hypertension and pregnancy

when using such an approach. While some authors advocate radiographic imaging before placement of an epidural catheter in patients with a shunt in situ,14 others do not find it necessary.73,74 In support of the second opinion, Bedard states there is no need for imaging studies if the interspace selected for epidural anesthesia is either above or below the scar of the shunt and the midline approach is followed, since the shunt catheter is directed laterally just underneath the skin.73 Nevertheless, attention must be given while removing the epidural catheter because there is always the theoretical risk of shunt entanglement. If abnormal resistance is felt during attempts to remove the catheter, imaging studies should be carried out before further manipulation.73 Another issue that arises in patients with a shunt in situ is the possible loss of local anesthetic into the peritoneal cavity, which could result in inadequate anesthesia. Bedson et al. claim that spinal anesthesia is unsuitable if a lumboperitoneal shunt is in situ; spread of local anesthetic is possible due to indeterminate circulation of CSF between the intrathecal space and the peritoneal cavity.70 In fact, Kaul et al. have reported a pattern of quick offset of the block after repeated doses of lidocaine intrathecally, possibly due to rapid washout of lidocaine through the shunt into the peritoneal cavity.14 On the other hand, a functioning shunt might limit the risk of raising intracranial pressure with large volumes of local anesthetic. The last matter of concern is the possibility of infection of the shunt catheter. The rate of lumboperitoneal shunt infection is approximately 1% per year.75 Controversy exists regarding the need for antibiotic prophylaxis. Prophylactic vancomycin and gentamicin have been administered for shunt infection.72 In contrast, the most relevant, though retrospective, study by Landwehr et al. included eight patients with 25 pregnancies over 16 years; they suggested that antibiotics are unnecessary for uncomplicated vaginal delivery in patients with either lumboperitoneal or ventriculoperitoneal shunts.54 Considering the reported experience to date, in our view, neuraxial anesthesia is feasible and a reasonable option in patients with lumboperitoneal shunts in situ. Spinal anesthesia has also been described recently in a parturient with a ventriculoperitoneal shunt, as there is no contraindication for neuraxial block in this set of circumstances.76 Physicians must bear in mind the possibility of shunt malfunction during pregnancy due mainly to uterine enlargement,77,78 while malfunction might also occur after operative delivery, possibly due to obstruction from blood clots.79

655

the planned approach should minimize the risk of a rise in intracranial pressure associated with rapid sequence induction and laryngoscopy.27 Another problem associated with pregnancy that arises is the increased risk of difficult intubation, probably because of fluid retention81 and the possible aspiration of gastric contents, since, as already discussed, these patients are often obese. Beta-blockers or hydralazine can be used to attenuate rises in ICP. Hyperventilation is not indicated as it reduces uterine blood flow and may cause fetal hypoxia and acidosis due to maternal hypocarbia.82 Hypoxia must also be avoided. If a central line is required, the internal jugular vein seems to be a safe approach in patients with elevated ICP.83 Postdural puncture headache in IIH Postdural puncture headache (PDPH), a well-known complication of accidental dural puncture, is attributed to ‘‘low CSF pressure syndrome’’ after CSF volume loss, which causes a downward pull on pain-sensitive structures, such as the meninges, vessels, and nerves.84,85 Cerebrospinal fluid hypotension is extremely uncommon in patients with IIH, even following dural puncture. As a consequence, this subgroup of parturients rarely develops PDPH. In fact, PDPH is so rare in patients with IIH that it is considered a paradoxical complication. In two cases wherein PDPH has been reported, the headache was managed successfully with an epidural blood patch.14,86 Clinicians should bear in mind that symptoms of IIH, such as headache and diplopia, might be confused with PDPH.

Conclusions In conclusion, although IIH is rare, there are special considerations for anesthetic management in parturients with this disorder. Even though these patients have an elevated ICP, the most important consideration is the fact that there is no contraindication to either spinal or epidural anesthetic techniques since uncal herniation does not occur in these patients. Special attention must be given to IIH parturients with lumboperitoneal or ventriculoperitoneal shunts in whom, under special precautions, neuraxial anesthesia might also be performed. In all cases, the main goal is to avoid further increases in ICP. Competing interests

None declared.

General anesthesia in pregnant women with IIH References General anesthesia for Cesarean delivery in parturients with IIH is recommended only when absolutely necessary, since the aim of treatment lies in minimizing increases in ICP.9,31 If a parturient with IIH requires general anesthesia,

1. Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 1937; 106: 492-513. 2. Quincke H. Uber Meningitis serosa: Sammlung linische Vortra 67. Inn Med 1893; 23: 655-94.

123

656 3. Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989; 46: 1049-51. 4. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875-7. 5. Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand 2010; 121: 71-82. 6. Hannerz J, Ericson K. The relationship between idiopathic intracranial hypertension and obesity. Headache 2009; 49: 178-84. 7. Rowe FJ, Sarkies NJ. The relationship between obesity and idiopathic intracranial hypertension. Int J Obes Relat Metab Disord 1999; 23: 54-9. 8. Ooi LY, Walker BR, Bodkin PA, Whittle IR. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis? Br J Neurosurg 2008; 22: 187-94. 9. Tang RA. Management of idiopathic intracranial hypertension in pregnancy. MedGenMed 2005; 7: 40. 10. Tang RA, Dorotheo EU, Schiffman JS, Bahrani HM. Medical and surgical management of idiopathic intracranial hypertension in pregnancy. Curr Neurol Neurosci Rep 2004; 4: 398-409. 11. Rothner AD, Brust JC. Pseudotumor cerebri. Report of a familial occurrence. Arch Neurol 1974; 30: 110-1. 12. Traviesa DC, Schwartzman RJ, Glaser JS, Savino P. Familial benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1976; 39: 420-3. 13. Gumma AD. Recurrent benign intracranial hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 115: 244. 14. Kaul B, Vallejo MC, Ramanathan S, Mandell GL, Krohner RG. Accidental spinal analgesia in the presence of a lumboperitoneal shunt in an obese parturient receiving enoxaparin therapy. Anesth Analg 2002; 95: 441-3. 15. Peterson CM, Kelly JV. Pseudotumor cerebri in pregnancy. Case reports and review of literature. Obstet Gynecol Surv 1985; 40: 323-9. 16. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990; 10: 331-5. 17. Friedman DI. Pseudotumor cerebri presenting as headache. Expert Rev Neurother 2008; 8: 397-407. 18. Randhawa S, Van Stavern GP. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Opin Ophthalmol 2008; 19: 445-53. 19. Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41: 239-44. 20. Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 2008; 8: 87-93. 21. Evans RW, Friedman DI. Expert opinion: the management of pseudotumor cerebri during pregnancy. Headache 2000; 40: 495-7. 22. Marcelis J, Silberstein SD. Idiopathic intracranial hypertension without papilledema. Arch Neurol 1991; 48: 392-9. 23. Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 1998; 51: 245-9. 24. Sher NA, Wirtschafter J, Shapiro SK, See C, Shapiro I. Unilateral papilledema in ‘benign’ intracranial hypertension (pseudotumor cerebri). JAMA 1983; 250: 2346-7. 25. Wattamwar PR, Baheti NN, Radhakrishnan A. Idiopathic intracranial hypertension presenting as unilateral papilledema. Neurol India 2010; 58: 818-9. 26. Zamecki KJ, Frohman LP, Turbin RE. Severe visual loss associated with idiopathic intracranial hypertension (IIH) in pregnancy. Clin Ophthalmol 2007; 1: 99-103. 27. Aly EE, Lawther BK. Anaesthetic management of uncontrolled idiopathic intracranial hypertension during labour and delivery using an intrathecal catheter. Anaesthesia 2007; 62: 178-81.

123

I. Karmaniolou et al. 28. Huna-Baron R, Kupersmith MJ. Idiopathic intracranial hypertension in pregnancy. J Neurol 2002; 249: 1078-81. 29. Capobianco DJ, Brazis PW, Cheshire WP. Idiopathic intracranial hypertension and seventh nerve palsy. Headache 1997; 37: 286-8. 30. Speer C, Pearlman J, Phillips PH, Cooney M, Repka MX. Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri. Am J Ophthalmol 1999; 127: 236-7. 31. Bagga R, Jain V, Das CP, et al. Choice of therapy, mode of delivery in idiopathic intracranial hypertension during pregnancy. MedGenMed 2005; 7: 42. 32. Koontz WL, Herbert WN, Cefalo RC. Pseudotumor cerebri in pregnancy. Obstet Gynecol 1983; 62: 324-7. 33. Janny P, Chazal J, Colnet G, Irthum B, Georget AM. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981; 15: 168-74. 34. Johnston I, Kollar C, Dunkley S, Assaad N, Parker G. Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci 2002; 9: 273-8. 35. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996; 46: 198-202. 36. Sugerman HJ, DeMaria EJ, Felton WL 3rd, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997; 49: 507-11. 37. Nedelmann M, Kaps M, Mueller-Forell W. Venous obstruction and jugular valve insufficiency in idiopathic intracranial hypertension. J Neurol 2009; 256: 964-9. 38. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-5. 39. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol 2004; 24: 138-45. 40. Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998; 105: 1686-93. 41. De Simone R, Ranieri A, Bonavita V. Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis. Neurol Sci 2010; 31(Suppl 1): S33-9. 42. Scoffings DJ, Pickard JD, Higgins JN. Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2007; 78: 911-2. 43. Lee SW, Gates P, Morris P, Whan A, Riddington L. Idiopathic intracranial hypertension; immediate resolution of venous sinus ‘‘obstruction’’ after reducing cerebrospinal fluid pressure to \ 10cmH(2)O. J Clin Neurosci 2009; 16: 1690-2. 44. Acheson JF. Idiopathic intracranial hypertension and visual function. Br Med Bull 2006; 79-80: 233-44. 45. Henry SD, Jacques S. Benign intracranial hypertension in pregnancy. JACEP 1979; 8: 323-5. 46. Babur H, Torres Q, Savitz MH. Lumboperitoneal shunts. Mt Sinai J Med 2000; 67: 272-3. 47. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997; 49: 734-9. 48. Woodworth GF, McGirt MJ, Elfert P, Sciubba DM, Rigamonti D. Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension. Stereotact Funct Neurosurg 2005; 83: 12-6. 49. Abu-Serieh B, Ghassempour K, Duprez T, Raftopoulos C. Stereotactic ventriculoperitoneal shunting for refractory idiopathic intracranial hypertension. Neurosurgery 2007; 60: 1039-43. 50. Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 2000; 107: 1907-12. 51. Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised

Idiopathic intracranial hypertension and pregnancy

52. 53. 54.

55.

56.

57. 58.

59.

60.

61. 62.

63.

64.

65. 66.

67.

68.

69.

70.

intracranial pressure. J Neurol Neurosurg Psychiatry 1994; 57: 1426-9. Uretsky S. Surgical interventions for idiopathic intracranial hypertension. Curr Opin Ophthalmol 2009; 20: 451-5. Ko MW. Idiopathic intracranial hypertension. Curr Treat Options Neurol 2011; 13: 101-8. Landwehr JB Jr, Isada NB, Pryde PG, Johnson MP. Evans Mi, Canady AI. Maternal neurosurgical shunts and pregnancy outcome. Obstet Gynecol 1994; 83: 134-7. Shapiro S, Yee R, Brown H. Surgical management of pseudotumor cerebri in pregnancy: case report. Neurosurgery 1995; 37: 829-31. Holmes LB, Kawanishi H, Munoz A. Acetazolamide: maternal toxicity, pattern of malformations, and litter effect. Teratology 1988; 37: 335-42. Holmes LB, Trelstad RL. The early limb deformity caused by acetazolamide. Teratology 1979; 20: 289-95. Tellone CI, Baldwin JK, Sofia RD. Teratogenic activity in the mouse after oral administration of acetazolamide. Drug Chem Toxicol 1980; 3: 83-98. Lee AG, Pless M, Falardeau J, Cappozoli T, Wall M, Kardon RH. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am J Ophthalmol 2005; 139: 855-9. Paruchuri SR, Lawlor M, Kleinhomer K, Mason L, Johnson C. Risk of cerebellar tonsillar herniation after diagnostic lumbar puncture in pseudotumor cerebri. Anesth Analg 1993; 77: 403-4. Sullivan HC. Fatal tonsillar herniation in pseudotumor cerebri. Neurology 1991; 41: 1142-4. Hart A, David K, Powell M. The treatment of ‘acquired tonsillar herniation’ in pseudotumour cerebri. Br J Neurosurg 2000; 14: 563-5. Lam FC, Wheatley MB, Mehta V. Treatment of secondary tonsillar herniation by lumboperitoneal shunt revision. Can J Neurol Sci 2007; 34: 237-42. Payner TD, Prenger E, Berger TS, Crone KR. Acquired Chiari malformations: incidence, diagnosis, and management. Neurosurgery 1994; 34: 429-34. Galbert MW, Marx GF. Extradural pressures in the parturient patient. Anesthesiology 1974; 40: 499-502. Palop R, Choed-Amphai E, Miller R. Epidural anesthesia for delivery complicated by benign intracranial hypertension. Anesthesiology 1979; 50: 159-60. Worrell J, Lane S. Impact of pseudotumor cerebri (idiopathic intracranial hypertension) in pregnancy: a case report. AANA J 2007; 75: 199-204. Grocott HP, Mutch WA. Epidural anesthesia and acutely increased intracranial pressure. Lumbar epidural space hydrodynamics in a porcine model. Anesthesiology 1996; 85: 1086-91. Hilt H, Gramm HJ, Link J. Changes in intracranial pressure associated with extradural anaesthesia. Br J Anaesth 1986; 58: 676-80. Bedson CR, Plaat F. Benign intracranial hypertension and anaesthesia for caesarean section. Int J Obstet Anesth 1999; 8: 288-90.

657 71. Abouleish E, Ali V, Tang RA. Benign intracranial hypertension and anesthesia for cesarean section. Anesthesiology 1985; 63: 705-7. 72. Kim K, Orbegozo M. Epidural anesthesia for cesarean section in a parturient with pseudotumor cerebri and lumboperitoneal shunt. J Clin Anesth 2000; 12: 213-5. 73. Bedard JM, Richardson MG, Wissler RN. Epidural anesthesia in a parturient with a lumboperitoneal shunt. Anesthesiology 1999; 90: 621-3. 74. Heckathorn J, Cata JP, Barsoum S. Intrathecal anesthesia for cesarean delivery via a subarachnoid drain in a woman with benign intracranial hypertension. Int J Obstet Anesth 2010; 19: 109-11. 75. Rosenberg ML, Corbett JJ, Smith C, et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993; 43: 1071-2. 76. Goulart AP, Moro ET, Rios Rde P, Pires RT. Subarachnoid blockade for cesarean section in a patient with ventriculoperitoneal shunt: case report (Portuguese). Rev Bras Anestesiol 2009; 59: 471-5. 77. Cusimano MD, Meffe FM, Gentili F, Sermer M. Ventriculoperitoneal shunt malfunction during pregnancy. Neurosurgery 1990; 27: 969-71. 78. Samuels P, Driscoll DA, Landon MB, et al. Cerebrospinal fluid shunts in pregnancy. Report of two cases and review of the literature. Am J Perinatol 1988; 5: 22-5. 79. Hwang SC, Kim TH, Kim BT, Im SB, Shin WH. Acute shunt malfunction after cesarean section delivery: a case report. J Korean Med Sci 2010; 25: 647-50. 80. Douglas MJ, Flanagan ML, McMorland GH. Anaesthetic management of a complex morbidly obese parturient. Can J Anaesth 1991; 38: 900-3. 81. Pilkington S, Carli F, Dakin MJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth 1995; 74: 638-42. 82. Peng AT, Blancato LS, Motoyama EK. Effect of maternal hypocapnia v. eucapnia on the fetus during caesarean section. Br J Anaesth 1972; 44: 1173-8. 83. Woda RP, Miner ME, McCandless C, McSweeney TD. The effect of right internal jugular vein cannulation on intracranial pressure. J Neurosurg Anesthesiol 1996; 8: 286-92. 84. Frank RL. Lumbar puncture and post-dural puncture headaches: implications for the emergency physician. J Emerg Med 2008; 35: 149-57. 85. Amorim JA, Valenc¸a MM. Postdural puncture headache is a risk factor for new postdural puncture headache. Cephalalgia 2008; 28: 5-8. 86. Lussos SA, Loeffler C. Epidural blood patch improves postdural puncture headache in a patient with benign intracranial hypertension. Reg Anesth 1993; 18: 315-7.

123